Battle lines are being drawn between establishment Democrats and progressive liberals in Congress over the idea of single-payer healthcare; an antitrust lawsuit filed in 2016 by states over 2 generic drugs has expanded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs; HHS will consider whether to approve work requirements for Medicaid expansion in Virginia.
Battle lines are being drawn between establishment Democrats and progressive liberals in Congress over the idea of single-payer healthcare. The partnership that helped Democrats save the Affordable Care Act a year ago is falling apart, Politico reported. Hospital associations, insurance groups, and other lobbies have teamed up to stop the idea of expanding Medicare for All, favored by progressives. The dispute could come into full view when Democrats take over the House of Representatives in January.
An antitrust lawsuit filed in 2016 by states over 2 generic drugs has expanded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs, The Washington Post reported. Executives at generic drug companies had their own shorthand to describe how they divvied up the market and set prices, according to the investigation. In one example, prices for albuterol soared more than 3400%.
HHS will consider whether to approve work requirements for Medicaid expansion in Virginia, The Hill reported. Expanding Medicaid was a top goal of Democratic Governor Ralph Northam, but Republicans agreed to support the expansion only if it came with work requirements. The proposal would be phased in, with some adults required to work 20 hours per month, increasing to 80 hours per month after 1 year, with some exceptions. As with other states, failure to comply would result in a loss of health coverage.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed CareÂź, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOsâ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More